A Study of PLB-002 in Advanced Solid Tumors
NCT07304128
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
PLB-002
Sponsor
Primelink BioTherapeitics(ShenZhen) Limited